Virtus LifeSci Biotech Clinical Trials ETF Rating $16.53 -1.01 (-5.76%) Closing price 04:10 PM EasternExtended Trading$16.52 -0.01 (-0.07%) As of 04:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsRatingsBuy This Stock Virtus LifeSci Biotech Clinical Trials ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BBC Aggregate RatingModerate Buy 2.95Holdings in BBC have an aggregate rating of Moderate Buy based on 1,067 analyst ratings issued in the past year covering 123 companies (98.0% of the portfolio).BBC Aggregate Price Target$16.53High Prediction$16.53Average Prediction$16.53Low Prediction$16.53Holdings in BBC have an aggregate price target of $16.53 and a range of $16.53 to $16.53 covering 123 companies (98.0% of the portfolio).BBC Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy74 Buy rating(s)Moderate Buy41 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce2 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Virtus LifeSci Biotech Clinical Trials ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 100 BBC Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings1.59%AKROAkero Therapeutics$38.64-4.5%4.3272 of 5 stars3.00$76.29 97.4%9Positive NewsHigh Trading Volume1.44%SANASana Biotechnology$1.50-10.7%3.1292 of 5 stars2.86$10.80 620.0%7News Coverage1.43%PTGXProtagonist Therapeutics$46.88-3.1%3.603 of 5 stars3.00$62.56 33.4%9Positive News1.35%XERSXeris Biopharma$5.08-7.5%3.8808 of 5 stars2.80$6.10 20.1%5High Trading Volume1.32%LQDALiquidia$14.51-1.6%2.5628 of 5 stars3.11$26.63 83.5%91.24%ARQTArcutis Biotherapeutics$14.98-4.2%3.4442 of 5 stars2.83$18.80 25.5%6Short Interest ↓Positive News1.19%MRUSMerus$39.60-5.9%2.3476 of 5 stars3.13$85.31 115.4%16News CoverageHigh Trading Volume1.18%ANABAnaptysBio$18.40-1.0%2.9504 of 5 stars2.73$35.11 90.8%11Buyback Announcement1.12%SMMTSummit Therapeutics$18.80-2.5%2.8039 of 5 stars3.00$35.44 88.5%10News Coverage1.10%BLTEBelite Bio$65.00-1.8%2.1867 of 5 stars3.00$96.67 48.7%41.08%MLYSMineralys Therapeutics$13.84-12.8%3.07 of 5 stars3.00$27.00 95.1%3Gap UpHigh Trading Volume1.07%ETNB89bio$6.80-6.5%3.0354 of 5 stars2.90$27.56 305.2%10Gap Down1.03%VERVVerve Therapeutics$4.14-9.4%1.815 of 5 stars3.00$25.50 515.9%61.02%ALLOAllogene Therapeutics$1.37-6.2%3.0138 of 5 stars2.90$9.29 578.0%101.01%CNTACentessa Pharmaceuticals$13.23-8.0%2.9405 of 5 stars3.00$27.71 109.5%8Analyst ForecastAnalyst RevisionNews CoverageHigh Trading Volume1.01%SLNOSoleno Therapeutics$68.26-4.5%4.6236 of 5 stars3.22$98.86 44.8%9Analyst ForecastInsider TradeAnalyst RevisionNews CoverageHigh Trading Volume1.01%PRTAProthena$11.74-5.2%3.2772 of 5 stars2.75$55.00 368.5%8News CoveragePositive News0.99%REPLReplimune Group$8.40-13.8%3.6783 of 5 stars3.13$19.43 131.3%8Positive News0.99%CVACCureVac$2.72-1.8%3.8184 of 5 stars2.25$10.00 267.6%40.99%VIRVir Biotechnology$6.18-4.6%3.6672 of 5 stars2.83$35.67 477.1%6News Coverage0.98%BEAMBeam Therapeutics$17.64-9.7%3.1894 of 5 stars3.00$49.45 180.4%14Short Interest ↑High Trading Volume0.98%SNDXSyndax Pharmaceuticals$12.01-2.2%3.6916 of 5 stars2.90$36.20 201.4%10Positive News0.98%ZYMEZymeworks$11.62-2.4%2.6209 of 5 stars2.88$21.00 80.7%8Positive News0.97%RNAAvidity Biosciences$26.74-9.4%2.5437 of 5 stars3.00$66.69 149.4%13Positive News0.95%ORICORIC Pharmaceuticals$5.53-0.9%4.0159 of 5 stars3.00$18.86 241.0%9News CoverageHigh Trading Volume0.95%OMEROmeros$7.91-3.8%3.6011 of 5 stars2.80$22.50 184.5%5Analyst ForecastNews CoverageGap UpHigh Trading Volume0.95%ITOSiTeos Therapeutics$5.63-5.7%2.5148 of 5 stars3.00$25.75 357.4%40.94%DNTHDianthus Therapeutics$16.83-7.2%1.3596 of 5 stars3.22$54.33 222.8%90.93%CGONCG Oncology$22.05-10.0%1.1495 of 5 stars3.10$63.88 189.7%10Earnings ReportAnalyst ForecastNews Coverage0.93%EYPTEyePoint Pharmaceuticals$5.05-6.8%1.8527 of 5 stars3.00$26.63 427.2%9Positive News0.93%NAMSNewAmsterdam Pharma$18.38-10.2%2.5969 of 5 stars3.00$43.33 135.8%6Short Interest ↑News CoverageHigh Trading Volume0.93%VRDNViridian Therapeutics$12.56-6.8%1.2373 of 5 stars2.75$35.70 184.2%12Positive News0.92%MNMDMind Medicine (MindMed)$5.54-5.3%2.2044 of 5 stars3.23$25.11 353.3%130.92%ELVNEnliven Therapeutics$18.88-4.1%2.6417 of 5 stars3.20$38.75 105.2%5News CoverageGap Up0.91%CAPRCapricor Therapeutics$9.48-0.1%2.0426 of 5 stars3.00$34.50 263.9%6Positive News0.91%COGTCogent Biosciences$5.79-3.3%2.1673 of 5 stars2.75$14.43 149.2%8News Coverage0.90%EWTXEdgewise Therapeutics$20.13-8.5%1.9373 of 5 stars2.88$45.38 125.4%80.90%ABUSArbutus Biopharma$3.48-0.3%1.5505 of 5 stars3.00$5.50 58.0%4Earnings ReportAnalyst Upgrade0.90%XENEXenon Pharmaceuticals$30.64-8.7%2.4083 of 5 stars3.00$57.38 87.3%9Analyst UpgradeNews CoveragePositive NewsHigh Trading Volume0.89%QUREuniQure$9.91-6.5%2.5271 of 5 stars2.82$38.80 291.5%11Analyst Forecast0.89%RXRXRecursion Pharmaceuticals$5.09-3.8%2.1283 of 5 stars2.40$8.25 62.1%50.88%RVMDRevolution Medicines$33.62-4.9%4.2269 of 5 stars3.08$65.23 94.0%13Analyst ForecastNews CoveragePositive News0.88%CYTKCytokinetics$37.50-6.7%4.0585 of 5 stars2.94$82.00 118.7%18Insider TradeAnalyst RevisionNews CoveragePositive News0.87%APGEApogee Therapeutics$35.61-4.7%2.1932 of 5 stars3.00$92.17 158.8%6Positive News0.87%ACLXArcellx$60.70-7.5%2.2742 of 5 stars3.13$108.46 78.7%15Positive News0.87%AVBPArriVent BioPharma$18.03-2.5%1.4285 of 5 stars3.17$39.00 116.3%6Positive News0.87%CELCCelcuity$9.29-8.1%1.6103 of 5 stars3.14$30.17 224.7%7Earnings ReportAnalyst ForecastNews CoverageHigh Trading Volume0.87%RNACCartesian Therapeutics$12.49-5.2%2.5074 of 5 stars2.80$42.14 237.4%10Gap Up0.86%SRRKScholar Rock$30.06-6.5%4.086 of 5 stars3.00$42.67 41.9%6Positive News0.86%GLUEMonte Rosa Therapeutics$4.43-4.5%3.1953 of 5 stars2.75$15.50 249.9%4Short Interest ↓Positive News0.85%CMPSCOMPASS Pathways$2.79-2.4%3.3564 of 5 stars3.00$20.20 624.0%60.85%NUVBNuvation Bio$1.76-0.3%1.9646 of 5 stars3.25$8.75 398.6%40.84%PHVSPharvaris$14.83-5.5%1.5446 of 5 stars3.00$40.50 173.1%40.84%PCVXVaxcyte$32.23-14.6%2.0072 of 5 stars3.00$136.50 323.5%9Analyst ForecastNews CoveragePositive NewsHigh Trading Volume0.84%IRONDisc Medicine$47.15-5.0%3.134 of 5 stars3.09$93.80 98.9%11Positive News0.84%NUVLNuvalent$68.00-4.1%2.3787 of 5 stars2.91$113.44 66.8%11News CoveragePositive NewsHigh Trading Volume0.84%KYMRKymera Therapeutics$25.24-7.8%1.3339 of 5 stars2.87$56.36 123.3%15Positive NewsHigh Trading Volume0.82%ARCTArcturus Therapeutics$9.43-11.0%3.3801 of 5 stars3.13$59.20 527.8%8Positive News0.80%KURAKura Oncology$6.38-3.3%4.26 of 5 stars2.92$25.50 299.7%120.80%LENZLENZ Therapeutics$26.01+1.2%1.7302 of 5 stars3.13$41.67 60.2%80.80%ABCLAbCellera Biologics$2.09-6.3%2.08 of 5 stars2.67$7.00 234.9%30.80%CLDXCelldex Therapeutics$16.85-7.2%1.6255 of 5 stars2.89$54.33 222.5%90.80%NGNENeurogene$9.65-17.6%2.3004 of 5 stars3.13$59.80 519.7%8High Trading Volume0.79%SYRESpyre Therapeutics$15.30-5.2%1.9979 of 5 stars3.13$50.33 229.0%8High Trading Volume0.78%SVRASavara$2.86+3.2%1.5404 of 5 stars2.83$8.83 208.9%6Earnings ReportAnalyst RevisionGap Up0.78%SLRNAcelyrin$2.51+1.6%3.1408 of 5 stars2.40$9.60 282.5%5Positive News0.78%TSHATaysha Gene Therapies$1.27-9.0%2.7306 of 5 stars3.00$6.63 423.7%8News CoveragePositive NewsGap Up0.78%WVEWave Life Sciences$7.74-4.2%4.5535 of 5 stars3.00$22.60 192.0%10Analyst RevisionGap Down0.77%RLAYRelay Therapeutics$2.47-5.7%2.2006 of 5 stars2.90$19.80 701.6%10News Coverage0.77%RGNXREGENXBIO$6.76-5.5%4.587 of 5 stars2.86$32.78 384.9%70.77%CATXPerspective Therapeutics$1.96-8.0%3.0867 of 5 stars3.17$14.44 637.0%12Analyst ForecastAnalyst RevisionNews Coverage0.75%CGEMCullinan Therapeutics$7.50-0.9%2.1427 of 5 stars3.00$32.86 338.1%8Positive News0.74%AUTLAutolus Therapeutics$1.41-9.0%3.0323 of 5 stars3.00$9.32 561.0%6Analyst ForecastPositive News0.73%ATXSAstria Therapeutics$5.40+1.1%1.7249 of 5 stars3.29$26.60 392.6%7Positive News0.73%MLTXMoonLake Immunotherapeutics$36.35-7.0%2.1496 of 5 stars3.00$80.50 121.5%80.73%TRMLTourmaline Bio$14.24-6.4%1.9563 of 5 stars3.00$45.20 217.4%6Positive News0.73%BHVNBiohaven$22.60-6.0%3.9612 of 5 stars3.07$62.77 177.8%150.72%IDYAIDEAYA Biosciences$14.77-9.8%3.5039 of 5 stars2.93$53.58 262.8%15News CoverageHigh Trading Volume0.72%BCAXBicara Therapeutics$12.66-2.8%N/A3.13$36.50 188.3%8Earnings ReportAnalyst RevisionGap Down0.72%TYRATyra Biosciences$8.72-6.2%2.0058 of 5 stars3.00$30.83 253.6%6Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageHigh Trading Volume0.71%ARWRArrowhead Pharmaceuticals$12.20-4.2%3.4441 of 5 stars2.60$41.44 239.7%100.71%NTLAIntellia Therapeutics$6.66-6.3%4.4457 of 5 stars2.63$37.56 463.9%19High Trading Volume0.71%NRIXNurix Therapeutics$10.47-11.9%1.9608 of 5 stars2.83$30.88 195.0%18High Trading Volume0.71%IMNMImmunome$6.26-7.0%2.1151 of 5 stars3.00$25.50 307.3%60.70%IMVTImmunovant$15.20-11.1%2.5412 of 5 stars3.00$41.00 169.7%10High Trading Volume0.70%RCKTRocket Pharmaceuticals$5.81-12.9%4.5809 of 5 stars2.92$43.00 640.1%12High Trading Volume0.69%STOKStoke Therapeutics$6.23-6.3%3.5389 of 5 stars3.13$24.67 295.9%8Positive NewsHigh Trading Volume0.69%TNGXTango Therapeutics$1.28-6.6%1.7228 of 5 stars3.00$12.33 863.5%7Short Interest ↑News Coverage0.68%GPCRStructure Therapeutics$15.79-8.8%2.0546 of 5 stars3.00$81.29 414.8%8News CoverageHigh Trading Volume0.68%MREOMereo BioPharma Group$2.17-3.6%2.4133 of 5 stars3.25$7.71 255.5%8Earnings ReportAnalyst RevisionNews Coverage0.68%DNLIDenali Therapeutics$12.29-9.6%4.3815 of 5 stars2.94$37.20 202.7%18Positive NewsHigh Trading Volume0.67%OLMAOlema Pharmaceuticals$3.34-11.2%2.6919 of 5 stars3.00$26.75 700.9%40.65%SLNSilence Therapeutics$2.42-14.2%2.0781 of 5 stars2.71$40.67 1,580.4%70.65%ALTAltimmune$4.74-5.2%2.5011 of 5 stars2.89$20.83 339.5%90.64%CRNXCrinetics Pharmaceuticals$30.62-8.7%4.3748 of 5 stars2.92$73.00 138.4%13News CoverageHigh Trading Volume0.64%KROSKeros Therapeutics$9.55-6.3%3.6464 of 5 stars2.57$42.33 343.3%14Analyst ForecastNews Coverage0.64%PRMEPrime Medicine$1.79-10.3%2.3604 of 5 stars3.10$13.38 649.3%100.63%VERAVera Therapeutics$22.02-8.3%3.103 of 5 stars3.20$64.67 193.7%10News CoveragePositive News0.63%ZNTLZentalis Pharmaceuticals$1.39-12.6%1.8903 of 5 stars2.44$8.24 493.1%9Earnings ReportAnalyst RevisionNews Coverage0.62%IMTXImmatics$4.00-11.3%1.8173 of 5 stars3.20$16.67 316.7%5Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageHigh Trading Volume This page (NYSEARCA:BBC) was last updated on 4/1/2025 by MarketBeat.com Staff From Our PartnersTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredNew “Trump” currency proposed in DCA former U.S. Presidential Advisor has come forward with a stern warning to investors: “Get out of tech, no...Paradigm Press | SponsoredIs Fort Knox Hiding Less Gold Than We Think? Find Out What That Means for YouWith gold prices recently soaring to record highs over $3,000 an ounce, and central banks rushing to accumulat...The Oxford Club | SponsoredHuge Elon-backed AI rollout begins – buy these nine stocksIf you suspect Elon Musk has an ulterior motive for coming to Washington, D.C.... You're 100% correct. ...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virtus LifeSci Biotech Clinical Trials ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Virtus LifeSci Biotech Clinical Trials ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.